Mowat-Wilson syndrome due to monosomy 2q22
MONDO:0016855Also known as: Hirschsprung disease and intellectual disability due to 2q22 microdeletion, Hirschsprung disease and intellectual disability due to del(2)(q22), Hirschsprung disease and intellectual disability due to monosomy 2q22, Mowat-Wilson syndrome due to 2q22 microdeletion, Mowat-Wilson syndrome due to del(2)q(22), Mowat-Wilson syndrome due to monosomy type 2q22
7 clinical trials for this condition and its sub-types, 0 tagged with Mowat-Wilson syndrome due to monosomy 2q22 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Real-World study tracks Epidyolex's Long-Term impact on seizures
Disease control OngoingThis study follows 158 people in France who are prescribed Epidyolex (a cannabidiol-based medicine) for seizures as part of their normal care. Researchers will track how long people stay on the treatment, side effects, seizure frequency, and changes in daily functioning and quali…
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New inhaler aims to stop prolonged seizures fast and safely
Symptom relief By invitation onlyThis study tests the long-term safety of an inhaled medication called Staccato alprazolam for people aged 12 and older who have prolonged seizures. About 300 participants will use the inhaler when a seizure starts to see if it stops the seizure quickly and without serious side ef…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC